MétaCan
Menu
Back to cohort

MRI study of long-term body composition alterations in HER2+ breast cancer survivors

2025· article· en· W4412805860 on OpenAlexaff
Edith Pituskin, Calvin Kruger, Rachel J. Skow, Devyn Walesniak, D. Ian Paterson, Mark J. Haykowsky, Richard B. Thompson, Amy A. Kirkham

Bibliographic record

VenueEuropean Heart Journal Supplements · 2025
Typearticle
Languageen
FieldMedicine
TopicChemotherapy-induced cardiotoxicity and mitigation
Canadian institutionsUniversity of TorontoUniversity of OttawaUniversity of Alberta
Fundersnot available
KeywordsMedicineBreast cancerTerm (time)OncologyInternal medicineCancer

Abstract

fetched live from OpenAlex

Abstract Background Early breast cancer (EBC) remains the most common invasive cancer in North American women. With improvements in detection, systemic therapies and supportive care, long-term survival in early stage disease now approaches 90%. In EBC survivors, fat pool distribution, specifically visceral and intermuscular fat (IMF) is associated with increased cardiovascular disease risk regardless of pre-existing risk factors or cancer treatments. We previously showed that 1 year after trastuzumab initiation, visceral fat and IMF volumes increased significantly while muscle volume decreased in HER2+ EBC patients. However, the longer-term effects of such exposures on body composition remain unknown. Purpose We hypothesized that over time, deleterious changes would progress with increasing fat and decreasing skeletal muscle in EBC patients exposed to trastuzumab-based chemotherapy. Methods A follow-up MRI study was conducted with prior participants of the MANTICORE (Multidisciplinary Approach to Novel Therapies In Cardio-Oncology REsearch) trial. Enrolment was limited to those without recurrent disease; 54 patients consented to participate. Eight scans were not included (tissues outside field of view, files unevaluable) thus 46 scans were included. The identical MRI protocol was used at all timepoints with five slices centered at the 3rd lumbar vertebra. Sum of volumes of muscle, IMF and visceral fat were measured using custom semi-automated software. Bones and organs were removed from the visceral fat pool. Repeated measures of ANOVA with appropriate post-hoc correction for multiple comparisons were performed at baseline, 3-month, 12-month, 24-month and 5 years. Results Participants were 58.6 ± 8.6 years of age and median 5.5 years had elapsed since trastuzumab completion. All were living independently with no cardiac events occurring in the intervening years. Ten had initiated cardiometabolic pharmacotherapy (beta-blockade, ACEI/ARB, diuretic or diabetes). Muscle mass increased over the 5 years (main effect of time, p=0.002); however, was lower at 1 year versus 3 months (Fig 1A). IMF also increased over 5 years (main effect of time, p=0.005) but the pattern was different with increases observed as early as 3-months (Fig 1B). Visceral fat increased up to 2 years then plateaued (main effect of time, p= 0.038; Fig 1C). Conclusions To our knowledge, this is the first and longest prospective study assessing changes in body composition in EBC using MRI both during and years after trastuzumab-based chemotherapy. Our data suggests that there may be ‘targetable’ timepoints for interventions such as pharmacotherapy, nutrition and exercise-based rehabilitation aiming to improve the quality and quantity of life in EBC survivors.Figure 1

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.084
Threshold uncertainty score0.453

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.025
GPT teacher head0.346
Teacher spread0.321 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueEuropean Heart Journal SupplementsSame topicChemotherapy-induced cardiotoxicity and mitigationFrench-language works237,207